Search Results Search Sort by RelevanceMost Recent Case and Commentary May 2022 Should Clinicians Ever Recommend Supplements to Patients Trying to Lose Weight? Melinda M. Manore, PhD, RDN and Megan Patton-Lopez, PhD, RDN Helping patients mitigate their risk of chronic disease is key, but dietary supplements are risky. AMA J Ethics. 2022;24(5):E345-352. doi: 10.1001/amajethics.2022.345. Viewpoint May 2022 Reimagining Roles of Dietary Supplements in Psychiatric Care Katherine Wu, MD and Erik Messamore, MD, PhD Government-supported review and safety monitoring is needed for dietary supplements’ use in the care of patients with mental illness. AMA J Ethics. 2022;24(5):E437-442. doi: 10.1001/amajethics.2022.437. Case and Commentary Jul 2023 Why We Need to Stop Labeling Behaviors Influencing a Person’s Weight Ideal or Healthy Madeline Ward, PhD Healthist views about body shape and weight are oppressive and lead to pernicious harms, especially to members of vulnerable groups. AMA J Ethics. 2023;25(7):E472-477. doi: 10.1001/amajethics.2023.472. Medicine and Society Oct 2023 What Might Aducanumab Teach Us About Clinicians’ Judgment About Whether to Recommend Emerging Alzheimer’s Interventions? Adam W. Burroughs, MD and Lewis P. Krain, MD Ethics questions about care of patients with AD could influence clinicians’ judgment about whether and when to recommend aducanumab. AMA J Ethics. 2023;25(10):E777-782. doi: 10.1001/amajethics.2023.777. History of Medicine May 2024 A Brief History of Antimicrobial Resistance Devin Hunt and Olivia S. Kates, MD, MA Resistance has dogged infectious disease treatment processes since we started using modern antimicrobials. AMA J Ethics. 2024;26(5):E408-417. doi: 10.1001/amajethics.2024.408.
Case and Commentary May 2022 Should Clinicians Ever Recommend Supplements to Patients Trying to Lose Weight? Melinda M. Manore, PhD, RDN and Megan Patton-Lopez, PhD, RDN Helping patients mitigate their risk of chronic disease is key, but dietary supplements are risky. AMA J Ethics. 2022;24(5):E345-352. doi: 10.1001/amajethics.2022.345.
Viewpoint May 2022 Reimagining Roles of Dietary Supplements in Psychiatric Care Katherine Wu, MD and Erik Messamore, MD, PhD Government-supported review and safety monitoring is needed for dietary supplements’ use in the care of patients with mental illness. AMA J Ethics. 2022;24(5):E437-442. doi: 10.1001/amajethics.2022.437.
Case and Commentary Jul 2023 Why We Need to Stop Labeling Behaviors Influencing a Person’s Weight Ideal or Healthy Madeline Ward, PhD Healthist views about body shape and weight are oppressive and lead to pernicious harms, especially to members of vulnerable groups. AMA J Ethics. 2023;25(7):E472-477. doi: 10.1001/amajethics.2023.472.
Medicine and Society Oct 2023 What Might Aducanumab Teach Us About Clinicians’ Judgment About Whether to Recommend Emerging Alzheimer’s Interventions? Adam W. Burroughs, MD and Lewis P. Krain, MD Ethics questions about care of patients with AD could influence clinicians’ judgment about whether and when to recommend aducanumab. AMA J Ethics. 2023;25(10):E777-782. doi: 10.1001/amajethics.2023.777.
History of Medicine May 2024 A Brief History of Antimicrobial Resistance Devin Hunt and Olivia S. Kates, MD, MA Resistance has dogged infectious disease treatment processes since we started using modern antimicrobials. AMA J Ethics. 2024;26(5):E408-417. doi: 10.1001/amajethics.2024.408.